Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bernard Carbonnelle"'
Autor:
Laurent Marsollier, Estelle Deniaux, Priscille Brodin, Agnès Marot, Christelle Mbondji Wondje, Jean-Paul Saint-André, Annick Chauty, Christian Johnson, Fredj Tekaia, Edouard Yeramian, Pierre Legras, Bernard Carbonnelle, Gilles Reysset, Sara Eyangoh, Geneviève Milon, Stewart T Cole, Jacques Aubry
Publikováno v:
PLoS Medicine, Vol 4, Iss 2, p e64 (2007)
BackgroundBuruli ulcer is a severe human skin disease caused by Mycobacterium ulcerans. This disease is primarily diagnosed in West Africa with increasing incidence. Antimycobacterial drug therapy is relatively effective during the preulcerative stag
Externí odkaz:
https://doaj.org/article/3adebf2a90184a298afb9887cb7973e8
Autor:
Bernard Carbonnelle, Stewart T. Cole, Gilles Reysset, Laurent Marsollier, Wafa Frigui, Jacques Aubry, Jean-Paul Saint André, Geneviève Milon
Publikováno v:
Cellular Microbiology. 9:347-355
The severe skin-destructive disease caused by Mycobacterium ulcerans, named Buruli ulcer, is the third most important mycobacterial disease in humans after tuberculosis and leprosy. Recently we demonstrated that M. ulcerans could colonize the salivar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::258565f04a6a218daea24bff6cfe1043
https://doi.org/10.1111/j.1462-5822.2006.00790.x
https://doi.org/10.1111/j.1462-5822.2006.00790.x
Autor:
Jean-Paul Saint André, Jacques Aubry, Geneviève Milon, Pamela L. C. Small, Bernard Carbonnelle, Pierre Legras, Emmanuelle Coutanceau, Stéphanie Guadagnini, Stewart T. Cole, Laurent Marsollier
Publikováno v:
Cellular Microbiology. 7:935-943
Mycobacterium ulcerans was first identified as the causative agent of Buruli ulcer; this cutaneous tissue-destructive process represents the third most important mycobacterial disease in humans after tuberculosis and leprosy. More recently other life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c1091576906aebc804869aa870c39ae
https://doi.org/10.1111/j.1462-5822.2005.00521.x
https://doi.org/10.1111/j.1462-5822.2005.00521.x
Autor:
Timothy P. Stinear, Bernard Carbonnelle, Jacques Aubry, Sandra Bourdon, Jean Paul Saint Andre, Anne-Lise Manceau, Raymond Robert, Laurent Marsollier, Pierre Legras, Christine Audrain, Henri Kouakou
Publikováno v:
Applied and Environmental Microbiology. 70:1097-1103
Mycobacterium ulcerans is the causative agent of Buruli ulcer, one of the most common mycobacterial diseases of humans. Recent studies have implicated aquatic insects in the transmission of this pathogen, but the contributions of other elements of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1c36c0c0f830326a842621e7740c994
https://doi.org/10.1128/aem.70.2.1097-1103.2004
https://doi.org/10.1128/aem.70.2.1097-1103.2004
Autor:
Sara Eyangoh, Geneviève Milon, Christelle Mbondji Wondje, Agnès Marot, Fredj Tekaia, Jacques Aubry, Priscille Brodin, Stewart T. Cole, Laurent Marsollier, Christian Johnson, Estelle Deniaux, Bernard Carbonnelle, Pierre Legras, Annick Chauty, Jean-Paul Saint-André, Gilles Reysset, Edouard Yeramian
Publikováno v:
PLoS Medicine
PLoS Medicine, 2007, 4 (2), pp.e64. ⟨10.1371/journal.pmed.0040064⟩
PLoS Medicine, Vol 4, Iss 2, p e64 (2007)
PLoS Medicine, Public Library of Science, 2007, 4 (2), pp.e64. ⟨10.1371/journal.pmed.0040064⟩
PLoS Medicine, 2007, 4 (2), pp.e64. ⟨10.1371/journal.pmed.0040064⟩
PLoS Medicine, Vol 4, Iss 2, p e64 (2007)
PLoS Medicine, Public Library of Science, 2007, 4 (2), pp.e64. ⟨10.1371/journal.pmed.0040064⟩
International audience; BACKGROUND: Buruli ulcer is a severe human skin disease caused by Mycobacterium ulcerans. This disease is primarily diagnosed in West Africa with increasing incidence. Antimycobacterial drug therapy is relatively effective dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76df5469024434cef6b7a25458b76199
https://www.hal.inserm.fr/inserm-00700851
https://www.hal.inserm.fr/inserm-00700851
Autor:
Laurent, Marsollier, Jacques, Aubry, Emmanuelle, Coutanceau, Jean-Paul Saint, André, Pamela L, Small, Geneviève, Milon, Pierre, Legras, Stéphanie, Guadagnini, Bernard, Carbonnelle, Stewart T, Cole
Publikováno v:
Cellular microbiology. 7(7)
Mycobacterium ulcerans was first identified as the causative agent of Buruli ulcer; this cutaneous tissue-destructive process represents the third most important mycobacterial disease in humans after tuberculosis and leprosy. More recently other life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6a2649210ab10c151fe6e29686495f5f
https://pubmed.ncbi.nlm.nih.gov/15953026
https://pubmed.ncbi.nlm.nih.gov/15953026
Autor:
Annick Chauty, Pierre Legras, Stewart T. Cole, Bernard Carbonnelle, Laurent Marsollier, Jean-Paul Saint André, Richard W. Merritt, Jacques Aubry, Tchibozo Sévérin, Anne-Lise Manceau
Publikováno v:
Applied and environmental microbiology. 70(10)
Accumulative indirect evidence of the epidemiology of Mycobacterium ulcerans infections causing chronic skin ulcers (i.e., Buruli ulcer disease) suggests that the development of this pathogen and its transmission to humans are related predominantly t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c0a3704a05094b95db3af9e416a40d
https://pubmed.ncbi.nlm.nih.gov/15466578
https://pubmed.ncbi.nlm.nih.gov/15466578
Autor:
Anne Lise Manceau, Pierre Legras, Ghislaine Prévot, Christopher Payan, Nadine Honoré, Laurent Marsollier, Bernard Carbonnelle, Henri Kouakou
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, Elsevier, 2003, 22 (6), pp.562-566. ⟨10.1016/S0924-8579(03)00240-1⟩
International Journal of Antimicrobial Agents, Elsevier, 2003, 22 (6), pp.562-566. ⟨10.1016/S0924-8579(03)00240-1⟩
International audience; The effectiveness of rifampicin (RIF), amikacin (AMK) and their combination were estimated in the treatment of mice experimentally infected by Mycobacterium ulcerans and the risk of relapse after the treatment was evaluated. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78d894c31e3373d2d57477259d75d6e
https://hal.univ-guyane.fr/hal-03284775
https://hal.univ-guyane.fr/hal-03284775
Publikováno v:
La Revue du praticien. 52(19)
Today, the diagnosis tests for tuberculosis are based on: the observation of acid-fast-bacilli after Ziehl-Neelsen staining or fluorescent microscopy, the growth of a culture, the study of drug sensibility, the observation of granulomatous tissue les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::645766011093f6e0b175387fcdec4cd1
https://pubmed.ncbi.nlm.nih.gov/12602232
https://pubmed.ncbi.nlm.nih.gov/12602232
Autor:
Pierre Legras, Henri Kouakou, Bernard Carbonnelle, Nadine Honoré, Anne Lise Manceau, Stewart T. Cole, Laurent Marsollier
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2003, 47 (4), pp.1228-1232. ⟨10.1128/AAC.47.4.1228-1232.2003⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2003, 47 (4), pp.1228-1232. ⟨10.1128/AAC.47.4.1228-1232.2003⟩
Antimicrobial Agents and Chemotherapy, 2003, 47 (4), pp.1228-1232. ⟨10.1128/AAC.47.4.1228-1232.2003⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2003, 47 (4), pp.1228-1232. ⟨10.1128/AAC.47.4.1228-1232.2003⟩
By use of a murine model for Buruli ulcer, Mycobacterium ulcerans was found to be susceptible to rifampin, with the MIC being 0.5 to 1 μg/ml. Three mutants were isolated after rifampin monotherapy. Two were resistant to rifampin at 8 μg/ml, and one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2c567b6e96a612a29cccfb5aeef4de
https://www.hal.inserm.fr/inserm-03400832
https://www.hal.inserm.fr/inserm-03400832